Tag: Atrial Fibrillation
Anticoagulation May Help Prevent Dementia in A-Fib Patients
Even patients with a low risk of stroke could benefit, researchers say
Plasma Catecholamines Predict Post-Op A-Fib After Cardiac Sx
Composite preoperative catecholamine marker linked to four-fold increased occurrence of POAF
No Proof Azithromycin Ups Odds of Ventricular Arrhythmia
Patients on azithromycin no more likely to develop ventricular arrhythmia than those on amoxicillin
Larger Women Have Nearly Three-Fold Higher Risk of A-Fib
Risk of atrial fibrillation rises along with body size, but remain low overall, researchers say
Lower Risk of Gastrointestinal Bleeding for Apixaban
In non-valvular a-fib patients, risk of GI bleeding down for apixaban vs. rivaroxaban, dabigatran
Apixaban Tx Cost in A-Fib Meets U.S. Norms for Reasonable Value
Incremental cost of achieving longer life expectancy within accepted U.S. norm ($53,925/QALY)
ACC: Antithrombotic Benefit Found Lacking in Low-Risk A-Fib
Researchers found low-risk patients fared better without any antithrombotic therapy
Many A-Fib Patients Not Getting Appropriate Anticoagulation Rx
More than 80 percent of ischemic stroke patients weren't getting adequate anticoagulation
ACC: Zika Linked to Negative Cardiovascular Effects in Adults
Eight Venezuelan patients developed arrhythmias, heart failure after infection
NOACs Have Been Widely Adopted Into Practice
Non-vitamin K antagonist oral anticoagulants prescribed more often than vitamin K antagonists
